查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654284

腎功能檢測市場規模、佔有率、趨勢分析報告：按產品、最終用途、地區、細分市場預測，2025-2030 年

Kidney Function Tests Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

腎功能測試市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球腎功能檢測市場規模預計到2030年將達到13.9億美元，2025年至2030年期間的複合年成長率為6.7%。

腎臟疾病高發、研發活動活性化、市場參與企業的投資不斷增加以及技術創新等關鍵因素預計將顯著推動市場成長。此外，政府採取越來越多的舉措提供各種便利，例如診斷測試報銷，也可能成為推動市場發展的主要因素。

工業公司引入創新的腎功能測試正在增加這些診斷測試的採用。例如，2022 年 12 月，Journey Biosciences, Inc.推出了其主打產品 NaviDKD。這是一項基於生物標記的血液測試，可以在症狀出現前幾年評估糖尿病患者患腎臟病的風險。與取得專利的指南針彙報平台結合，該產品提供了可操作的見解，以管理和預防併發症的發生。預計此類發展將在預測期內推動市場發展。

此外，預計預測期內新產品開發的研發舉措將顯著推動市場成長。例如，2021年2月，德比和伯頓大學醫院、NHS基金會信託和諾丁漢大學的研究人員獲得了232萬美元的資助，用於幫助改善腎臟疾病的治療和診斷。調查團隊計劃使用多參數 MRI 掃描來評估患有 CKD 的患者。同樣，加拿大腎臟研究組織也獲得了 1,180 萬美元的新投資，以支持其 2027 年的活動。 Can-SOLVE慢性腎臟病網路是加拿大有史以來最大的腎臟研究舉措。

COVID-19 疫情導致全國住院人數增加和感染熱點增加。截至 2021 年 6 月，全球已出現至少三波新冠肺炎疫情，對醫院資源帶來巨大壓力，尤其是人力和透析設備和用品的可用性。此外，新冠肺炎疫情也影響了腎臟病患者的醫療保健服務。保持社交距離和門鎖成為世界各地的常態，導致其他衛生服務暫時關閉。疫情期間，由於非緊急諮詢和檢測服務被暫停，多種腎臟疾病的診斷也被推遲。

此外，預計研究期間腎臟疾病發生率的不斷上升將增加對診斷測試的需求。例如，根據美國國家腎臟基金會的數據，美國約有 3,700 萬人（即超過七分之一的成年人）患有某種形式的腎臟疾病。同樣，根據FDA發布的資料，美國每年約有10,000名兒童患有急性腎損傷（AKI）。這些孩子的存活率約為38%至43%。患有 AKI 的新生兒死亡率約為 60%。這些因素預計將促進新生兒血液透析機的需求並推動市場成長。

然而，對腎臟疾病的認知低預計會阻礙市場的成長。例如，據估計，美國約有 3700 萬成年人患有腎臟疾病，但約 90% 的人並不知道自己患有這種疾病。腎臟疾病的主要危險因子是高血壓、糖尿病、心臟病、肥胖和家族病史。然而，各政府機構已經啟動計畫來提高人們對腎功能測試的認知。例如，截至 2020 年 3 月，泰米爾納德邦腎臟研究基金會已進行了 1,279 次宣傳活動。

腎功能檢測市場報告重點

  • 根據產品，清關檢查部分佔據最大的市場佔有率。這些測試提供最佳的靈敏度和精確度，以最大限度地減少性能變化。由於其成本低廉且隨時可用，所以其採用率越來越高。
  • 根據最終用途，由於 CKD 盛行率不斷上升導致對體外診斷 (IVD) 測試的需求不斷成長，醫院部門預計將在 2024 年佔據市場佔有率。
  • 由於完善的醫療保健基礎設施、健全的報銷政策和政府舉措，北美在 2024 年佔據了全球市場的主導地位。
  • 由於中國和印度等新興經濟體針對 CKD 的宣傳活動不斷增多，預計亞太地區未來將顯著成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 腎功能檢測市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 腎功能檢測市場分析工具
    • 產業分析-波特五力分析
    • PESTEL 分析

第4章 腎功能檢測市場：產品評估與趨勢分析

  • 2024 年及 2030 年產品市場佔有率
  • 細分儀表板
  • 全球腎功能檢測市場（按產品）展望
  • 2018 年至 2030 年市場規模、預測及趨勢分析
    • 清除測試
    • 血液檢查
    • 尿液檢查
    • 稀釋和濃度測試
    • 其他測試

第 5 章腎功能檢測市場：最終用途估計與趨勢分析

  • 2024 年及 2030 年終端用途市場佔有率
  • 細分儀表板
  • 全球腎功能檢測市場前景（依最終用途）
  • 2018 年至 2030 年市場規模、預測及趨勢分析
    • 醫院
    • 診斷實驗室
    • 研究室和實驗室
    • 其他

第6章腎功能檢測市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018 年至 2030 年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • Key company market share analysis, 2024
    • Danaher
    • Danaher
    • F. Hoffmann-La Roche Ltd
    • Sysmex Corporation
    • Siemens Healthineers
    • Randox Laboratories Ltd
    • Quest Diagnostics
    • Acon Laboratories, Inc
    • Nova Biomedical Corporation
    • Laboratory Corporation Of America Holdings
Product Code: GVR-1-68038-721-6

Kidney Function Tests Market Growth & Trends:

The global kidney function tests market size is expected to reach USD 1.39 billion by 2030, registering at a CAGR of 6.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key factors such as high prevalence of kidney diseases, the rising R&D activities, increasing investments by market players, and technological innovations are anticipated to significantly drive the market growth. Moreover, the growing number of initiatives undertaken by the government to provide various facilities, such as reimbursement for diagnostic tests is a major factor likely to boost the market.

Introduction of innovative kidney function tests in the market by the operating players is increasing the adoption of these diagnostics tests. For instance, in December 2022, Journey Biosciences, Inc. launched its leading product-NaviDKD. It is a biomarker-based blood test, which evaluates the peril of renal disease in people with diabetes years before the symptoms appear. Along with its patented compass reporting platform, the product provides actionable insights for managing and preventing complications before they arise. Such developments are foreseen to fuel the market during the forecast period.

Furthermore, rising R&D initiatives for the development of novel products are expected to significantly fuel the market growth during the forecast period. For instance, in February 2021, Researchers from the University Hospitals of Derby and Burton, NHS Foundation Trust, and the University of Nottingham received USD 2.32 million in funding to help improve the treatment and diagnosis of renal diseases. Researchers will use multi-parametric MRI scanning to evaluate patients suffering from CKD. Similarly, the Canadian kidney research organization received a new USD 11.8 million investment to support its work through 2027. The Can-SOLVE Chronic Kidney Disease Network is the largest-ever kidney research initiative in Canada.

The COVID-19 pandemic has been associated with increase in hospitalization and infection hotspots around the country. There were at least three separate waves of COVID-19 around the world by June 2021 that put a significant strain on hospital resources, especially labor and availability of dialysis equipment & supplies. In addition, the COVID-19 pandemic has affected healthcare services for renal disease patients. Social distancing and lockdown were mandate norms, globally, leading to temporary closure of other medical services. The diagnosis of several renal diseases deferred during the pandemic due to suspension of non-urgent visits and testing services.

Moreover, the growing prevalence of renal diseases is projected to increase the demand for diagnostic tests during the study period. For instance, according to The National Kidney Foundation, Inc., an estimated 37 million people in the U.S., i.e., more than one in seven adults, are living with some form of renal disease. Similarly, according to data published by FDA, about 10,000 children in the U.S. develop acute kidney infections (AKI) every year. These children possess a survival rate of around 38%-43%. The mortality rate for neonates with AKI is around 60%. Such factors are likely to drive the demand for neonatal hemodialysis, thereby driving the market growth.

On the other hand, low awareness regarding renal diseases is expected to hamper the market growth. For instance, In the U.S., an estimated 37 million adults have kidney disease and about 90% remain unaware of the condition. Major risk factors for the disease are high blood pressure and diabetes as well as heart disease, obesity, & family history of kidney disease. However, various government bodies are initiating programs for raising awareness of kidney function tests. For instance, Tamilnadu Kidney Research Foundation has conducted 1,279 awareness programs until March 2020.

Kidney Function Tests Market Report Highlights:

  • By product, the clearance tests segment held the largest share of the market. These tests ensure that there is minimal variation in performance owing to their optimum sensitivity and precision. The low cost and easy availability of these products in the market lead to their increased adoption.
  • By end-user, the hospitals segment accounted for the dominant market share in 2024, due to the rising demand for IVD tests because of increase in the prevalence of CKD.
  • North America dominated the global market in 2024 due to the well-established healthcare infrastructure, favorable reimbursement policies and government initiatives in the region.
  • Asia Pacific is expected to grow considerably in the future owing to the increasing awareness programs about CKD in emerging economies, such as China & India.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End use
    • 1.2.3. Application
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Kidney Function Tests Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Introduction Of Innovative Kidney Function Tests
      • 3.2.1.2. Increasing Investments In R&D
      • 3.2.1.3. Increasing Prevalence Of Acute Kidney Injury And Associated Chronic Kidney Disease
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Low Awareness Regarding Kidney Diseases
  • 3.3. Kidney Function Tests Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Kidney Function Tests Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Kidney Function Tests Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Clearance Tests
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 4.4.2. Blood Tests
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Urine Tests
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Dilution & Concentration Tests
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Other Tests
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Kidney Function Tests Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Kidney Function Tests Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Diagnostic Laboratories
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Research Laboratories And Institutes
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Kidney Function Tests Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2024
    • 7.3.2. Danaher
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Danaher
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. F. Hoffmann-La Roche Ltd
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Sysmex Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Siemens Healthineers
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Randox Laboratories Ltd
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Quest Diagnostics
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Acon Laboratories, Inc
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Nova Biomedical Corporation
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Laboratory Corporation Of America Holdings
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives

List of Tables

  • Table 1 Premarket approval process
  • Table 2 Key companies adopting expansion strategy
  • Table 3 Key companies adopting collaboration strategy
  • Table 4 Key companies launching new products/services
  • Table 5 Key companies adopting partnership strategy
  • Table 6 List of Secondary Sources
  • Table 7 List of Abbreviations
  • Table 8 Global Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 9 Global Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10 Global Kidney Function Tests Market, by Region, 2018 - 2030 (USD Million)
  • Table 11 North America Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
  • Table 12 North America Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 North America Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 14 U.S Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 U.S Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 16 Canada Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 17 Canada Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 18 Mexico Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Mexico Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 20 Europe Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 22 Europe Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 23 Germany Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Germany Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 25 UK Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 UK Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 27 France Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 28 France Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 Italy Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Italy Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 31 Spain Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Spain Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 33 Denmark Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 34 Denmark Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 35 Sweden Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 Sweden Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 37 Norway Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 38 Norway Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Japan Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Japan Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 44 China Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 45 China Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 46 India Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 India Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 48 South Korea Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 South Korea Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 50 Australia Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Australia Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 52 Singapore Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 53 Singapore Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 54 Thailand Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Thailand Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 56 Latin America Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
  • Table 57 Latin America Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 Latin America Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 59 Brazil Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Brazil Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 61 Argentina Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Argentina Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 63 Middle East & Africa Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
  • Table 64 Middle East & Africa Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 65 Middle East & Africa Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 66 South Africa Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 South Africa Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 68 Saudi Arabia Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 Saudi Arabia Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 UAE Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 UAE Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 72 Kuwait Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Kuwait Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Executives contacted
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Kidney function tests market estimation process
  • Fig. 10 Market snapshot
  • Fig. 11 Market segmentation and scope
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Market drivers impact
  • Fig. 16 Reported causes of end-stage renal disease in the U.S.
  • Fig. 17 Percentage of U.S. adults aged 18 or older with CKD
  • Fig. 18 Market restraint relevance analysis (Current & future impact)
  • Fig. 19 Kidney function test market: product outlook and key takeaways
  • Fig. 20 Kidney function tests market: product movement analysis
  • Fig. 21 Clearance tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Blood tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Urine tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Dilution & concentration tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Other tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Kidney function test market: end-use outlook and key takeaways
  • Fig. 27 Kidney function test market: end-use movement analysis
  • Fig. 28 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Research laboratories and institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Regional marketplace: key takeaways
  • Fig. 33 North America kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 France kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 India kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Singapore kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 UAE kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Market participant categorization
  • Fig. 63 Kidney function tests market share analysis, 2024
  • Fig. 64 Strategic framework